We have once again an exciting program for 2016! We have responded to your comments from 2014 and are continuing the one track model, so no one misses a talk. There are several major themes: The Long Road to Alzheimer’s (describing the slow progression of the disease from many aspects), Hot NEW Topics, Stress, and both Medical and Practical information for community providers.
We will start of the program with the Leon Thal Memorial Lecture given by Dr. Jeffrey Cummings, discussing the molecules and mechanisms of Alzheimer’s. This talk leads off the Long Road to Alzheimer’s theme. Dr. Cummings is a world renowned speaker with an easy to understand style. He will be followed by Dr. Peter Nelson, a pathologist, who will describe the progression of pathology in the disease and Dr. Bill Jagust, who will talk about early biomarkers and the staging of Alzheimer’s.
The new Director of the UC San Diego Alzheimer’s Disease Cooperative Study, Dr. Howard Feldman, will give us an update on clinical trials past, present and future. He is followed by Dr. Ralph Greenspan who helped craft the NIH BRAIN Initiative, part of a Presidential focus aimed at revolutionizing our understanding of the human brain. It hopes to explore how the human body records, processes, utilizes, stores, and retrieves information, all at the speed of thought.
The first afternoon will bring us a group of practical and useful topics. For the first time, we will have a presentation on Native Americans and the cross cultural issues surrounding dementia. We are bringing back some popular topics such as technology and driving and introducing Dr. John Morley, talking about frailty. Dr. Ann Mayo will discuss a very creative quilt project for long term care.
On day two, we will begin with the Robert Katzman Memorial Lecture, presented by one of his trainees, Dr. Claudia Kawas. Dr. Kawas has spoken for us many times and will update us on her research on the oldest old, persons over 90 years of age. She has appeared on 60 minutes with stories of her research participants. We are bringing back the topic of genetics, since it is a hot area of research with a new speaker, Dr. Andrew Saykin, followed by Dr. Pierre Tariot and a discussion of the use of genetics in clinical trials. Stress is always in the news and the new topic of Mindfulness to counteract stress will be presented by Drs. Guerry Peavy and Marguerite Manteau-Rao.
We will close our conference with a series of 5 presentations for community physicians with discussions on unusual case studies, brain imaging, sleep disorders, cognitive screening and our all-time most popular speaker, Dr. Daniel Sewell, talking once again about behavior modifying medications. We believe we have once again put together a great program for you. We look forward to meeting you in May.
Douglas Galasko, MD and James B. Brewer, MD, PhD
At the end of the course, participants should be able to:
- Describe “the long road to Alzheimer’s” and the signs we can now see along the way.
- Discuss the current methods to detect preclinical changes in the brain that might indicate future onset of Alzheimer’s disease.
- Identify several innovative tools that can be used in a long-term care setting.
- Describe the dangers and precautions needed in working with frail elderly.
- Discuss lessons we can learn about successful aging from those more than 90 years old.
- Define the role of genetics in current clinical trials.
- Summarize the cultural challenges in conducting a dementia assessment in a Native American population.
- Explain how a community physician would make the decision to order brain imaging studies for a possible dementia patient.
- Identify sleep disorders common in the elderly.
- Distinguish how various medications can be used to manage behavioral symptoms in dementia.
Physicians, psychologists, researchers, nurses, nurse practitioners, physician assistants, residential care and nursing home administrators, social workers and pharmacists.
The Shiley-Marcos Alzheimer’s Disease Research Center (ADRC) was established in 1984 as one of the original five Alzheimer’s Disease Centers supported by the National Institute on Aging, a branch of the National Institutes of Health.
Under the direction of Robert Katzman, MD, a number of scientists and scholars renowned for their work in Alzheimer’s disease and aging assembled at UC San Diego to conduct investigations into the etiology and effects of this devastating disease. Working with multiple facilities around the country, our clinicians and basic researchers have been instrumental in helping the scientific community understand the clinical presentation and the basic biology of the disease. Our clinical studies have also uncovered information that has led to the development of therapies that help slow the progression of the disease and, in some cases, improve memory.
The center’s clinical research program enrolls both people with Alzheimer’s disease and related dementias, as well as control subjects. Since its inception, more than 2,500 volunteers have participated in our research studies, including more than 350 participants in our Hispanic program.
Follow UC San Diego CME on
UC San Diego School of Medicine, Continuing Medical Education • 9500 Gilman Drive, MC0947 • La Jolla, CA 92093-0947
Phone: (858) 534-3940 • Toll-Free: (888) 229-6263 • Fax: (858) 534-1896 • E-mail: firstname.lastname@example.org • Website: cme.ucsd.edu
Content is subject to change without notice. Please refer to the activity website for the most current information.
Official website of the University of California, San Diego. Copyright ©2016 Regents of the University of California. All rights reserved.